We are live on ! Find out more
CTSO icon

Cytosorbents Corp

37 hedge funds and large institutions have $10M invested in Cytosorbents Corp in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $362K | Put options by funds: $93K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

25% more capital invested

Capital invested by funds: $8.06M → $10M (+$1.98M)

6% more funds holding

Funds holding: 3537 (+2)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
12
Reduced
8
Closed
4
Calls
$362K
Puts
$93K
Net Calls
+$269K
Net Calls Change
+$223K

CTSO Hedge Fund Activity: Q3 2016 in Review

37 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2016, worth a combined $10M — up 25% from $8.06M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CTSO positions and 4 closed out — a net gain of 2 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Fortaleza Asset Management, adding an estimated $131K. The largest seller was Raymond James & Associates, cutting an estimated $1.22M.

  • 37 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2016, up from 35 in Q2 2016.
  • Funds reported $10M of Cytosorbents Corp stock for Q3 2016, up 25% quarter-over-quarter.
  • 6 funds opened new Cytosorbents Corp positions in Q3 2016 and 4 closed out, a net change of +2 holders.
  • The largest Cytosorbents Corp buyer in Q3 2016 was Fortaleza Asset Management, an estimated $131K added.
  • The largest Cytosorbents Corp seller in Q3 2016 was Raymond James & Associates, an estimated $1.22M sold.

Based on aggregated 13F filings for Q3 2016.